Fortress Biotech Inc. (NASDAQ:FBIO) went down by -7.12% during the previous trading session, and it is maintaining the win ahead of Friday’s trading session. The share price of the Biotechnology giant went up by $2.61 to trade ended Friday trading at $2.81. This is down from the $2.81 price recorded on Thursday’s trading session. Thanks to this latest performance, FBIO is closer to the higher price 52-week target of $19.00 and further from the lowest price target of $4.50. Its performance from the start of the year has also been positive, with FBIO up by 1.56% year-to-date.
Fortress Biotech Inc. (FBIO) started the day trading at $2.81 and recorded an intraday high of $2.89. It also recorded an intraday low of $2.55 during Friday’s trading session. Fortress Biotech Inc. is a very active stock that recorded a trading volume that is more than 91.82% of the average daily trading volume on Friday. The stock’s trading volume on Friday was 7934215, which is more than 91.82 of the total average daily trading volume of 648.72K.
Fortress Biotech Inc. (NASDAQ:FBIO) 2020 Performance Impressive
The increase in FBIO’s stock price on Friday saw its overall performance boost over the past few months. We can quantify the performance of the stock so far this year using a few metrics. The 52-week high price of FBIO currently stands at $3.20, which is higher than the current trading price of the stock by 18.44%. However, FBIO’s current trading price is -150.96% lower than the 52-week low price of $1.04. In terms of trading volume, Fortress Biotech Inc. currently experienced healthy participation during the last trading session. 7934215 shares of Fortress Biotech Inc. were traded on the stock exchange on Friday, which is more than 91.82% of the 648.72K average trading volume of the stock.
The performance of the stock has been positive over the past year. FBIO’s performance over the past one year has seen it surge by 77.55%, while the stock has gone up by 4.82% in the last six months. The quarterly performance of FBIO currently stands at 52.63%, and it is down by -10.92% in the last month. The only negative figure was from the weekly performance, which currently reads -13.58%. At the time of writing FBIO’s report, the company has a total market cap of $231.79M, making it one of the largest publicly-traded companies in the world.Fortress Biotech Inc. also has over 93 employees all over the world.
FBIO Insider Activities
For Fortress Biotech Inc., insiders hold 16.60% of all company shares. The insider transactions over the past six months are up by 10.00%. During that period, insiders bought 2,103,072 shares in 8 transactions. In that same period, insiders sold 0 of their shares in 0 transactions. After these transactions, insiders at Fortress Biotech Inc. now hold 23.2M shares, which is over 14.09% of the total company stocks. Institutional investors currently hold a large chunk of the FBIO shares, as they control 28.13% of the company’s total stock.
FBIO Fundamental Analysis
For Fortress Biotech Inc., the stock’s diluted earnings per share (EPS) stands at -0.92. In the coming year, analysts expect the EPS to be -0.60. The EPS growth will up over the next five years to 43.40% after plunging by -5.40% in the previous five years. In terms of revenue, Fortress Biotech Inc.’s quarterly sales (YOY) is shrinking at -0.27, which is higher than the average annual revenue of -5.40% over the past half a decade.
The Return on Investment (ROI) on Fortress Biotech Inc.’s stock currently stands at -79.70%. The gross margin of the company is 71.90%.
At the moment, Fortress Biotech Inc.’s Total Debt to Equity ratio stands at 2.43, and they have a long-term Debt to Equity ratio of 2.04.
FBIO Technical Analysis
The Simple Moving Average (SMA) is one of the most powerful technical indicators. The 20-day Simple Moving Average of FBIO currently stands at -9.41%, while the SMA50 is 1.79%. The biggest one is the SMA200, which is currently reading 24.92% ahead of Friday’s trading session. The Relative Strength Index of this stock is 46.00.
